Cancer Genetic Testing: Hereditary Cancer Risk Assessment and BRCA Testing
Test Overview
- Sample Required: Blood or saliva
- Fasting Rules: Not required
- Turnaround Time (TAT): 10–14 business days
- Base Cost: [Insert Current 2026 Price]
Cancer genetic testing is a powerful tool that analyzes your DNA to identify inherited mutations that increase the risk of developing certain types of cancer. This testing is particularly relevant for individuals with a strong family history of cancer, as approximately 5–10% of all cancers are hereditary.
What Is Cancer Genetic Testing?
Cancer genetic testing, also known as hereditary cancer risk assessment, examines specific genes associated with inherited cancer syndromes. The test uses Next-Generation Sequencing (NGS) to analyze multiple genes simultaneously, including well-known ones like BRCA1 and BRCA2, as well as other genes linked to breast, ovarian, colorectal, and other cancers.
Unlike diagnostic tests that detect existing cancer, genetic testing identifies predispositions—helping you and your healthcare provider make proactive decisions about surveillance, prevention, and risk reduction.
Why Is Cancer Genetic Testing Important?
Approximately 5–10% of all cancers are caused by inherited genetic mutations. Identifying these mutations can:
- Enable early and more frequent screening (e.g., MRI for breast cancer)
- Guide preventive surgeries (e.g., prophylactic mastectomy or oophorectomy)
- Inform targeted therapies for affected family members
- Provide clarity for family planning decisions
For individuals with a family history of cancer, genetic testing can be life-saving.
Hereditary Cancer Syndromes and Associated Genes
The table below summarizes common hereditary cancer syndromes and the genes typically analyzed in a comprehensive panel.
| Syndrome | Associated Genes | Primary Cancers |
|---|---|---|
| Hereditary Breast and Ovarian Cancer (HBOC) | BRCA1, BRCA2 | Breast, Ovarian, Prostate, Pancreatic |
| Lynch Syndrome | MLH1, MSH2, MSH6, PMS2, EPCAM | Colorectal, Endometrial, Ovarian, Stomach |
| Li-Fraumeni Syndrome | TP53 | Breast, Sarcoma, Brain, Adrenal |
| Familial Adenomatous Polyposis (FAP) | APC | Colorectal, Duodenal, Thyroid |
Who Should Consider Cancer Genetic Testing?
You may be a candidate if you have any of the following:
- Multiple family members with the same type of cancer
- Cancer diagnosed at an unusually young age (e.g., breast cancer before age 50)
- More than one primary cancer in the same individual
- Known pathogenic variant in a cancer susceptibility gene in a relative
- Ashkenazi Jewish ancestry (higher risk for BRCA mutations)
The Testing Process
At DNA Labs India, the process is streamlined and patient-friendly:
- Sample Collection: A simple blood draw or saliva sample is collected at our certified collection centers.
- DNA Extraction: DNA is isolated from the sample using standardized protocols.
- Next-Generation Sequencing (NGS): The relevant genes are sequenced using NGS technology, which allows simultaneous analysis of multiple genes with high accuracy.
- Variant Analysis: Bioinformatics tools and clinical geneticists interpret the data to identify pathogenic variants, likely pathogenic variants, and variants of uncertain significance (VUS).
- Report Generation: A comprehensive report is prepared, including clinical recommendations and a referral for genetic counseling.
Understanding Your Results
Results are categorized as:
- Positive: A pathogenic variant was found, indicating an increased risk. Preventive measures and enhanced screening are recommended.
- Negative: No pathogenic variant was detected. This does not eliminate cancer risk but suggests it is not significantly elevated due to known hereditary factors.
- Variant of Uncertain Significance (VUS): A genetic change was found, but its impact on cancer risk is not yet known. Further research and family testing may clarify.
Genetic counseling is strongly recommended before and after testing to help interpret results and make informed decisions.
Benefits and Limitations
Benefits:
- Early detection and prevention strategies
- Personalized risk assessment for family members
- Guidance for targeted therapies in affected individuals
Limitations:
- Not all hereditary cancer genes are covered in standard panels
- VUS results can cause anxiety without clear clinical action
- Genetic testing does not replace regular cancer screening
Why Choose DNA Labs India?
DNA Labs India is an ISO 9001 certified lab committed to accuracy and patient care. Our cancer genetic testing services include:
- Comprehensive NGS-based panels covering 50+ cancer-related genes
- Rapid turnaround time of 10–14 business days
- Expert genetic counseling support
- Affordable pricing with transparent billing
Frequently Asked Questions (FAQs)
1. Is cancer genetic testing covered by insurance?
Coverage varies by provider. DNA Labs India offers self-pay options and can provide documentation for insurance reimbursement.
2. How long does it take to get results?
Typically 10–14 business days after sample receipt.
3. Can I take the test if I have no family history?
Yes, but it is most beneficial for those with a personal or family history of cancer. Genetic counseling can help determine if testing is appropriate.
4. Will the test tell me if I have cancer?
No, it assesses genetic risk, not the presence of cancer. Diagnostic tests are separate.
5. How accurate is the test?
NGS-based testing is highly accurate, with >99% sensitivity for detecting variants in covered genes. All results are confirmed by Sanger sequencing when necessary.
Written by: [Author Name]
Medically Reviewed by: [Reviewer Name]
Last Updated: [Date]